Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras

EMBO Journal

Volumn 25, Issue 5, 2006, Pages 1093-1103

  Soon, Young Shin ^a   Young, Yil Bahk ^b   Ko, Jesang ^c   Chung, Il Yup ^a   Young, Seek Lee ^a   Downward, Julian ^d   Eibel, Hermann ^e   Sharma, Prem M ^f   Olefsky, Jerrold M ^f   Kim, Young Ho ^g   Lee, Bonghee ^h   Young, Han Lee ^a  

^a Hanyang University   (South Korea)

^b Yonsei University   (South Korea)

^c Korea University   (South Korea)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g Kyungpook National University   (South Korea)

^h Jeju National University School of Medicine   (South Korea)

Author keywords

Egr 1; Oncogenic H Ras; Phosphoinositide 3 kinase; Serum response element; Serum response factor

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; SERUM RESPONSE FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN 3T3; GENE CONTROL; GENE TARGETING; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; CELLS, CULTURED; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, RAS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); SERUM RESPONSE ELEMENT; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 33644861490     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600987     Document Type: Article

References (47)

1. Aicher WK, Sakamoto KM, Hack A, Eibel H (1999) Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol Int 18: 207-214
2. Baron V, Adamson ED, Calogero A, Ragona G, Mercola D (2005) The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin. Cancer Gene Ther; doi:10.1038/sj.cgt.7700896
3. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689
4. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ (1998) Increasing complexity of Ras signaling. Oncogene 17: 1395-1413
5. Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96: 4240-4245
6. Christy B, Nathans D (1989) Functional serum response elements upstream of the growth factor-inducible gene zif268. Mol Cell Biol 9: 4889-4895
7. Clarkson RW, Shang CA, Levitt LK, Howard T, Waters MJ (1999) Ternary complex factors Elk-1 and Sap-1a mediate growth hormone-induced transcription of egr-1 (early growth response factor-1) in 3T3-F442A preadipocytes. Mol Endocrinol 13: 619-631
8. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell 77: 841-852
9. de Belle I, Huang RP, Fan Y, Liu C, Mercola D, Adamson ED (1999) p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene 18: 3633-3642
10. Edwards SA, Darland T, Sosnowski R, Samuels M, Adamson ED (1991) The transcription factor, Egr-1, is rapidly modulated in response to retinoic acid in P19 embryonal carcinoma cells. Dev Biol 148: 165-173
11. Egawa K, Sharma PM, Nakashima N, Huang Y, Huver E, Boss GR, Olefsky JM (1999) Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J Biol Chem 274: 14306-14314
12. Galetic I, Maira SM, Andjelkovic M, Hemmings BA (2003) Negative regulation of ERK and Elk by protein kinase B modulates c-fos transcription. J Biol Chem 278: 4416-4423
13. Gire V, Wynford-Thomas D (2000) RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation. Oncogene 19: 737-744
14. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429-1439
15. Hipskind RA, Buscher D, Nordheim A, Baccarini M (1994) Ras/MAP kinase-dependent and -independent signaling pathways target distinct ternary complex factors. Genes Dev 8: 1803-1816
16. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J (1998) Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 273: 31327-31336
17. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72: 102-109
18. Joneson T, Bar-Sagi D (1997) Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med 75: 587-593
19. Krones-Herzig A, Adamson E, Mercola D (2003) Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. Proc Natl Acad Sci USA 100: 3233-3238
20. Liu C, Rangnekar VM, Adamson E, Mercola D (1998) Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5: 3-28
21. Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D (1999) The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 274: 4400-4411
22. Liu C, Yao J, Mercola D, Adamson E (2000) The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J Biol Chem 275: 20315-20323
23. Macara IG, Lounsbury KM, Richards SA, McKiernan C, Bar-Sagi D (1996) The Ras superfamily of GTPases. FASEB J 10: 625-630
24. Marte BM, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J (1997) R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol 7: 63-70
25. McCormick F (1999) Signalling networks that cause cancer. Trends Cell Biol 9: M53-M56
26. Parsons R (2004) Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 15: 171-176
27. Paterson H, Reeves B, Brown R, Hall A, Furth M, Bos J, Jones P, Marshall C (1987) Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell 51: 803-812
28. Price MA, Rogers AE, Treisman R (1995) Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J 14: 2589-2601
29. Ragione FD, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V (2003) p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem 278: 23360-23368
30. Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21: 267-271
31. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89: 457-467
32. Sakurada A, Hamada H, Fukushige S, Yokoyama T, Yoshinaga K, Furukawa T, Sato S, Yajima A, Sato M, Fujimura S, Horii A (1999) Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int J Oncol 15: 1069-1074
33. Schratt G, Weinhold B, Lundberg AS, Schuck S, Berger J, Schwarz H, Weinberg RA, Ruther U, Nordheim A (2001) Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol 21: 2933-2943
34. Shin SY, Kim CG, Ko J, Min DS, Chang JS, Ohba M, Kuroki T, Choi YB, Kim YH, Na DS, Kim JW, Lee YH (2004) Transcriptional and post-transcriptional regulation of the PKC delta gene by etoposide in L1210 murine leukemia cells: implication of PKC delta autoregulation. J Mol Biol 340: 681-693
35. Shin SY, Kim SY, Kim JH, Min DS, Ko J, Kang UG, Kim YS, Kwon TK, Han MY, Kim YH, Lee YH (2001) Induction of early growth response-1 gene expression by calmodulin antagonist trifluoperazine through the activation of Elk-1 in human fibrosarcoma HT1080 cells. J Biol Chem 276: 7797-7805
36. Spencer JA, Major ML, Misra RP (1999) Basic fibroblast growth factor activates serum response factor gene expression by multiple distinct signaling mechanisms. Mol Cell Biol 19: 3977-3988
37. Spencer ML, Theodosiou M, Noonan DJ (2004) NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/ proteasome system through a PEST degradation motif. J Biol Chem 279: 37069-37078
38. Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37-43
39. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617
40. Thyss R, Virolle V, Imbert V, Peyron JF, Aberdam D, Virolle T (2005) NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death. EMBO J 24: 128-137
41. Treisman R (1994) Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev 4: 96-101
42. Tsai JC, Liu L, Guan J, Aird WC (2000) The Egr-1 gene is induced by epidermal growth factor in ECV304 cells and primary endothelial cells. Am J Physiol 279: C1414-C1424
43. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Belle I (2001) The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 3: 1124-1128
44. Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A (1997) FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 14: 213-221
45. Wennstrom S, Downward J (1999) Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol Cell Biol 19: 4279-4288
46. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH (1995) Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533-541
47. Yu C-L, Prochownik EV, Imperiale MJ, Jove R (1993) Attenuation of serum inducibility of immediate early genes by oncoprotein in tyrosine kinase signaling pathways. Mol Cell Biol 13: 2011-2019